Genprex to Present TUSC2 Gene Research at GSA 2026 Meeting
Austin, Texas, United States, October 28, 2026 Genprex, Inc. has announced that research from its sponsored collaboration with Meharry...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Austin, Texas, United States, October 28, 2026 Genprex, Inc. has announced that research from its sponsored collaboration with Meharry...
Boston, Massachusetts, United States, October 28, 2026 TransCode Therapeutics, Inc., a clinical-stage biopharmaceutical company developing RNA-based cancer treatments, has...
NEW YORK — September 28, 2026 Immuneering Corporation presented new data at the 2026 AACR Conference on Pancreatic Cancer...
NEW YORK — September 28, 2026 Pfizer Inc. announced that it will present data from 45 company-sponsored, investigator-sponsored and...
NEW YORK — September 25, 2026 SELLAS Life Sciences Group presented new preclinical data for SLS009 (tambiciclib) in patient-derived...
Redmond, Washington, U.S., September 22, 2026 SystImmune, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...
Hong Kong, China, September 21, 2026 Akeso, Inc. has announced that nearly 30 clinical studies from its innovative biopharmaceutical...
Burr Ridge, Illinois, U.S., September 17, 2026 SkinCure Oncology has reported a new analysis suggesting that the annual number...
Providence, Rhode Island, USA, September 17, 2026 Nabsys, Inc. has announced the publication of research from Augusta University demonstrating...
SOUTH SAN FRANCISCO, Calif. — September 16, 2026 Mission Bio announced the launch of Tapestri® Triomics, a new expansion...
